High-Sensitivity C-Reactive Protein and Cardiovascular Disease
Top Cited Papers
- 1 July 2013
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 62 (5), 397-408
- https://doi.org/10.1016/j.jacc.2013.05.016
Abstract
No abstract availableFunding Information
- General Electric
This publication has 98 references indexed in Scilit:
- Within-Person Variability in High-Sensitivity C-Reactive ProteinJAMA Internal Medicine, 2012
- Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort studyThe Lancet, 2011
- C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection StudyThe Lancet, 2011
- The JUPITER Trial: Responding to the CriticsThe American Journal of Cardiology, 2010
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010
- Clinical Implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. Population: Insights From the ARIC (Atherosclerosis Risk in Communities) StudyJournal of the American College of Cardiology, 2009
- Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart DiseaseJAMA, 2009
- Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the CommunityJAMA, 2009
- An Assessment of Incremental Coronary Risk Prediction Using C-Reactive Protein and Other Novel Risk MarkersArchives of Internal Medicine, 2006
- Cardiovascular Mortality Risk in Chronic Kidney DiseaseJAMA, 2005